Time To Refresh Fda Issues Draft Guidance On Key Information And Informed Consent News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Earlier this month, the U.S. Food and Drug Administration ("FDA") issued a draft guidance, "Key Information and Facilitating Understanding in Informed Consent".

Drug administrationPurpose of the researchHuman servicesUs department of healthTreatments for researchFacilitating understandingInstitutional reviewCommon ruleCures actExpected durationForeseeable risksMedical treatmentsProposed ruleDraft guidanceFacilitating informed consentInstitutional review boards